» Authors » Raphael Calmon

Raphael Calmon

Explore the profile of Raphael Calmon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 877
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez D, Calmon R, Sanchez Aliaga E, Warren D, Warmuth-Metz M, Jones C, et al.
Radiology . 2022 Apr; 304(1):174-182. PMID: 35412366
Background Diffuse midline gliomas (DMG) are characterized by a high incidence of mutations and poorer outcome. The HERBY trial has provided one of the largest cohorts of pediatric DMGs with...
2.
Chegraoui H, Philippe C, Dangouloff-Ros V, Grigis A, Calmon R, Boddaert N, et al.
Cancers (Basel) . 2021 Dec; 13(23). PMID: 34885222
Tumour lesion segmentation is a key step to study and characterise cancer from MR neuroradiological images. Presently, numerous deep learning segmentation architectures have been shown to perform well on the...
3.
Calmon R, Dangouloff-Ros V, Varlet P, Deroulers C, Philippe C, Debily M, et al.
Eur Radiol . 2021 May; 31(12):8913-8924. PMID: 34003354
Objectives: The diffuse intrinsic pontine gliomas (DIPGs) are now defined by the type of histone H3 mutated at lysine 27. We aimed to correlate the multimodal MRI features of DIPGs,...
4.
Lemaitre H, Auge P, Saitovitch A, Vincon-Leite A, Tacchella J, Fillon L, et al.
Cereb Cortex . 2020 Nov; 31(3):1776-1785. PMID: 33230520
The first year of life is a key period of brain development, characterized by dramatic structural and functional modifications. Here, we measured rest cerebral blood flow (CBF) modifications throughout babies'...
5.
Rodriguez Gutierrez D, Jones C, Varlet P, Mackay A, Warren D, Warmuth-Metz M, et al.
Clin Cancer Res . 2020 Jan; 26(8):1856-1865. PMID: 31924736
Purpose: The HERBY trial evaluated the benefit of the addition of the antiangiogenic agent Bevacizumab (BEV) to radiotherapy/temozolomide (RT/TMZ) in pediatric patients with newly diagnosed non-brainstem high-grade glioma (HGG). The...
6.
Le Teuff G, Castaneda-Heredia A, Dufour C, Jaspan T, Calmon R, Devos A, et al.
Pediatr Blood Cancer . 2019 Oct; 67(1):e28032. PMID: 31595663
Aim: To assess objective response after two cycles of temozolomide and topotecan (TOTEM) in children with refractory or relapsed miscellaneous extracranial solid and central nervous system (CNS) tumors, including medulloblastoma...
7.
Saitovitch A, Lemaitre H, Rechtman E, Vincon-Leite A, Calmon R, Grevent D, et al.
Sci Rep . 2019 Jun; 9(1):9252. PMID: 31239453
Social behavior is extremely variable among individuals, and the neural basis of this variability is still poorly understood. In this study, we aimed to investigate the neural basis of interindividual...
8.
Geryes B, Calmon R, Donciu V, Khraiche D, Warin-Fresse K, Bonnet D, et al.
Phys Med . 2018 Jun; 49:99-104. PMID: 29866350
Objective: To demonstrate that the use of step-and-shoot (SAS) mode in paediatric cardiac CT angiography (CCTA) is possible at heart rates (HR) greater than 65 bpm, allowing low-dose acquisition with...
9.
Hoffman L, Veldhuijzen van Zanten S, Colditz N, Baugh J, Chaney B, Hoffmann M, et al.
J Clin Oncol . 2018 May; 36(19):1963-1972. PMID: 29746225
Purpose Diffuse intrinsic pontine glioma (DIPG) is a brainstem malignancy with a median survival of < 1 year. The International and European Society for Pediatric Oncology DIPG Registries collaborated to...
10.
Goya-Outi J, Orlhac F, Calmon R, Alentorn A, Nioche C, Philippe C, et al.
Phys Med Biol . 2018 Apr; 63(10):105003. PMID: 29633962
Few methodological studies regarding widely used textural indices robustness in MRI have been reported. In this context, this study aims to propose some rules to compute reliable textural indices from...